Health Care/Hospital
Foresee Pharmaceuticals Announces NDA for CAMCEVI(TM) 42MG Accepted for Review by the FDA
TAIPEI, Oct. 8, 2020 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee") announced today that the 505(b)(2) New Drug Application (NDA) for FP-001 LMIS 50mg, or CAMCEVI™ 42MG, a ready-to-use 6-month depot formulation of leuprolide mesylate, has been accepted for review by the ...
2020-10-09 06:39
2034
Biom'up Australian Market Growth Gathers Pace
Company optimally positioned to increase market share in highly valued Australian hemostat market, following positive feedback from physician usage of HEMOBLAST™ Bellows Building on inclusion on the Australian Register of Therapeutic Goods (ARTG) and agreed partnership with LHC in 2019 SAINT-PR...
2020-10-08 22:12
2595
EB Research Partnership and EB Research Foundation Come Together as Largest Global Organization Advancing Research for Epidermolysis Bullosa
As the leading EB research funders worldwide, the group will combine to leverage EBRP's innovative business model to accelerate treatments and cures NEW YORK and MELBOURNE, Australia, Oct. 9, 2020 /PRNewswire/ -- EB Research Partnership (EBRP), based inNew York, and EB Research Foundation (EBRF) ...
2020-10-08 21:00
2738
CrystalGenomics Appoints Gavin Choy, as President, CG Pharmaceuticals, Inc. to Lead Pipeline Expansion and Global Operations
SEOUL, South Korea, Oct. 7, 2020 /PRNewswire/ -- CrystalGenomics, Inc. (KOSDAQ: 083790), a commercial stage biopharmaceutical company that is dedicated to the discovery, development and commercialization of novel therapeutics in unmet medical need areas of inflammation, oncology, and infectious d...
2020-10-08 08:35
2227
Nagase R&D Center Increases Productivity of Rare Amino Acid "Ergothioneine" 1000-fold: Highest Production Efficiency Reported Using "Smart Cell" Technology
TOKYO, Oct. 7, 2020 /PRNewswire/ -- The Nagase R&D Center, the research and development arm of NAGASE & CO., LTD. based inTokyo, has been developing fermentative production technology for ergothioneine (EGT) (*1) and researching EGT's functions. Using revolutionary biotechnology developed as part...
2020-10-07 14:00
2104
CARsgen Therapeutics Granted Orphan Drug Designation by the US FDA for CT041 CLDN18.2 CAR-T Cells for the Treatment of Gastric and Gastroesophageal Junction Cancers
SHANGHAI, Oct. 5, 2020 /PRNewswire/ -- CARsgen Therapeutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced thatthe United States (US) Food and Drug Administration (FDA) has granted orphan drug designation to one of CARsgen's first-in-class drug candidates, CT041, for the t...
2020-10-05 18:00
5254
ITRI Wins Three 2020 R&D 100 Awards
HSINCHU, Oct. 5. 2020 /PRNewswire/ -- The R&D 100 Awards, often referred to as
"the Oscars of invention," or "the Nobel Prizes of Technology," has announced
its 2020 winners. The Industrial Technology Research Institute (ITRI
2020-10-05 15:37
2704
TaiGen filed US IND for its influenza antiviral TG-1000
TAIPEI, Taiwan, Oct. 4, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") announced today that it has filed an Investigational New Drug (IND) application with the US FDA for its influenza antiviral TG-1000. TG-1000 is a novel pan-influenza antiviral, which interrupts viral re...
2020-10-05 06:50
2371
Happiness Biotech Announced Receipt of FDA Registration For Its Hand Sanitizer
NANPING, China, Oct. 1, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company's hand sanitizer products have been registered with U.S. Food and Drug Administra...
2020-10-01 22:00
13032
Growing Global Demand for ESP Disc Replacements Leads to Formation of Independent Company -- Spine Innovations to Launch October 1
HEIMSBRUNN, France, Oct. 1, 2020 /PRNewswire/ -- The growing global demand for ESP disc replacements has led to the creation of an independent company called Spine Innovations, scheduled to launch onOctober 1, 2020. The new company will take over the entire spine business of its parent company FH...
2020-10-01 06:00
2685
Concord Medical Announces a Hoisting Ceremony for the Proton Therapy System of Guangzhou Concord Cancer Center
BEIJING, Sept. 30, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone...
2020-10-01 05:00
15675
Turning AI onto itself: AI algorithm detects when medical images will be difficult for radiologists or AI to make an effective diagnosis
SAN FRANCISCO, Sept. 30, 2020 /PRNewswire/ -- A new AI algorithm can identify when medical images are likely to be difficult for either a radiologist or AI to make an effective diagnosis. The algorithm can potentially be used to triage medical scans and highlight cases that warrant further in-dep...
2020-09-30 23:06
1975
I-Mab Receives China CDE Approval to Initiate Phase 3 Clinical Trial of Eftansomatropin in Pediatric Patients with Growth Hormone Deficiency
SHANGHAI and GAITHERSBURG, Md., Sept. 30, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the China Center for Drug Evaluation (CDE) has app...
2020-09-30 20:00
11790
The 11th China (Taizhou) International Medical Expo ended successfully
NANJING, China, Sept. 30, 2020 /PRNewswire/ -- From September 19 to 21, the 11th China (Taizhou) International Medical Expo was held at the China Medical City Exhibition Center. With the theme of "Development Trends in the Medical and Health Industry under the Epidemic", the current medical expo h...
2020-09-30 19:52
1710
111, Inc. Builds Digitally-enabled, Omni-channel Drug Commercialization Platform as Part of its Goal to Provide Full Life-cycle Healthcare Management Solutions for Patients
SHANGHAI, Sept. 30, 2020 /PRNewswire/ -- On September 24, 2020, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform dedicating to digitally connecting patients with drugs and healthcare services inChina, hosted its 3rd annual China Online Healthcare Summit and P...
2020-09-30 18:00
22297
TaiGen Biotechnology Out-Licensed Taigexyn (Nemonoxacin) to Luminarie Canada for Canada, Australia and New Zealand
TAIPEI, Sept. 30, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen")(Taiwan: 4157) today announced that they have signed an exclusive licensing agreement with Luminarie Canada Inc. ("Luminarie"), a leading Canadian pharmaceutical company, to develop and commercialize Taigexyn® ...
2020-09-30 15:51
1859
HeyGears Announces its Latest Innovations in Digital Manufacturing Solutions: A Clear Aligner Production Solution and UltraCraft A2D 4K
GUANGZHOU, China, Sept. 30, 2020 /PRNewswire/ -- At Dental South China International Expo, HeyGears announces two of its latest innovations in digital manufacturing solutions. First, HeyGears' clear aligner production solution that allows 24/7 mass production of clear aligner models and digitally...
2020-09-30 13:17
3217
JIECANG announced the official opening of the new headquarters at the 20th anniversary celebration
SHAOXING, China, Sept. 29, 2020 /PRNewswire/ -- On September 28, JIECANG celebrated its 20th anniversary in JIECANG Life and Health Industrial Park in Zhejiang. With its customer-centric strategy, strong product customization capabilities and production capacity, two decades of focus in linear mot...
2020-09-29 23:22
11420
VolitionRx Limited Announces Virtual Capital Markets Day 2020
AUSTIN, Texas, Sept. 29, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases, today announced it will host a capital market...
2020-09-29 20:00
9715
Cardiac Dimensions Announces $17.5 Million Series C Financing to Accelerate Sales Expansion of The Carillon Mitral Contour System®
Funds to be Used for Commercial Expansion in Europe and Australia KIRKLAND, Washington, Sept. 29, 2020 /PRNewswire/ -- Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today ann...
2020-09-29 20:00
1750
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5214
